Anaplasma platys and Thrombocytotropic Anaplasmosis in Dogs: Tick-Transmitted Pathogenesis and Diagnosis

Introduction

Anaplasma platys is an obligate intracellular bacterial pathogen belonging to the family Anaplasmataceae, order Rickettsiales [1, 2]. The organism is the etiologic agent of canine cyclic thrombocytopenia, also termed thrombocytotropic anaplasmosis, a disease characterized by recurrent episodes of platelet destruction and variable clinical manifestations [3, 4]. Since its first description in 1978, A. platys has been recognized as a globally distributed tick-borne pathogen of dogs, with the brown dog tick Rhipicephalus sanguineus sensu lato serving as the principal vector [5, 6]. The pathogen exhibits tropism for platelets, leading to a distinct cyclical pattern of parasitemia and thrombocytopenia that can be exploited for diagnostic timing [7, 8].

This article provides a detailed academic review of A. platys biology, its transmission ecology, pathogenic mechanisms, clinical presentation, and the spectrum of diagnostic modalities available to veterinary clinicians. Emphasis is placed on molecular detection methods, given their superior sensitivity and specificity over conventional microscopy [9, 10].

Taxonomy and Morphology

Anaplasma platys is classified within the genus Anaplasma, which also includes A. phagocytophilum, A. marginale, A. bovis, and A. ovis [11, 12]. Phylogenetic analyses based on 16S rRNA, groEL, and gltA gene sequences consistently place A. platys in a clade separate from other canine-infecting species [13, 14]. The bacterium appears as small, basophilic, coccoid to pleomorphic inclusions (mortulae) within the cytoplasm of infected platelets [15, 16]. Individual organisms measure approximately 0.3 to 0.5 µm in diameter, and the inclusions may contain one to several dozen bacteria [17, 18]. Unlike Ehrlichia canis, which infects monocytes, A. platys exhibits a strict tropism for platelets [19, 20]. The cell wall lacks lipopolysaccharide and is characterized by a thin peptidoglycan layer, a feature common to Anaplasmataceae [21, 22].

Life Cycle and Tick Transmission

The principal vector for A. platys is Rhipicephalus sanguineus sensu lato, the brown dog tick [23, 24]. Transmission occurs transstadially (from nymph to adult) but not transovarially, meaning that ticks acquire the pathogen during larval or nymphal feeding on a rickettsemic dog and transmit it during subsequent life stages [25, 26]. Experimental transmission has been demonstrated using infected R. sanguineus ticks [27, 28]. The pathogen has also been detected in other tick species, including Dermacentor and Haemaphysalis spp., though their vector competence remains incompletely defined [29, 30].

Once in the vertebrate host, A. platys enters platelets via receptor-mediated endocytosis [31, 32]. The bacterium replicates within a parasitophorous vacuole, avoiding lysosomal fusion through modulation of host cell signaling [33, 34]. Infected platelets are removed from circulation by the reticuloendothelial system, primarily in the spleen, leading to thrombocytopenia [35, 36]. The parasitemia follows a cyclical pattern of 10 to 14 days, correlating with waves of bacterial replication and immune-mediated clearance [37, 38]. This cycle results in a waxing and waning thrombocytopenia that can be detected on serial complete blood counts [39, 40].

Pathogenesis and Clinical Manifestations

The primary pathologic consequence of A. platys infection is thrombocytopenia, which can range from mild to severe [41, 42]. Platelet destruction occurs through two mechanisms: direct parasitism leading to lysis and immune-mediated destruction of both infected and uninfected platelets [43, 44]. Antiplatelet antibodies have been demonstrated in infected dogs, supporting the autoimmune component [45, 46]. In addition, complement activation and splenic sequestration contribute to platelet clearance [47, 48].

Clinical signs are highly variable. Many dogs remain subclinical, with thrombocytopenia detected incidentally during routine health screening [49, 50]. When clinical signs do occur, they include lethargy, fever, anorexia, pale mucous membranes, petechiation, ecchymosis, and epistaxis [51, 52]. Coinfections with other tick-borne pathogens, such as Ehrlichia canis, Babesia vogeli, and Hepatozoon canis, are common and may exacerbate clinical severity [53, 54, 55]. For instance, mixed infections of A. platys and E. canis produce more pronounced hematologic abnormalities than either infection alone [56, 57]. Pleural effusion and secondary infections, including Nocardia otitidiscaviarum, have also been reported in coinfected dogs [58, 59].

Laboratory findings typically include thrombocytopenia, mild anemia, and occasionally leukopenia [60, 61]. Automated impedance analyzers may generate platelet clump flags or low platelet counts that prompt manual blood smear examination [62, 63]. The cyclic nature of thrombocytopenia is a hallmark; platelet counts can fluctuate from normal to severely decreased (below 20,000/µL) over the course of days [64, 65]. Bleeding times may be prolonged, but disseminated intravascular coagulation is uncommon [66, 67].

Diagnosis

Microscopic Examination

Examination of Giemsa- or Wright-stained peripheral blood smears remains a widely accessible diagnostic method [68, 69]. Anaplasma platys mortulae appear as basophilic, intracytoplasmic inclusions within platelets, often at the periphery of the cell [70, 71]. Sensitivity is low (estimated 20-30%) and depends on the stage of parasitemia, with optimal detection during the peak of bacterial replication [72, 73]. Multiple smears over several days may be required due to cyclic parasitemia.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the 16S rRNA gene or heat shock protein genes (groEL, gltA) provide high sensitivity and specificity for A. platys detection [9, 25]. Conventional, nested, and real-time quantitative PCR formats are available [25]. Real-time PCR allows quantification of bacterial load and can be used to monitor response to therapy [10, 25]. Multiplex PCR panels that simultaneously detect A. platys, E. canis, Babesia spp., and other vector-borne agents are increasingly utilized in diagnostic laboratories [1, 51]. Reverse line blot hybridization assays have been compared with antigen-based rapid tests and show good concordance [20].

Advanced molecular techniques, including next-generation sequencing (NGS) metabarcoding and microfluidic PCR, enable broad-spectrum pathogen detection and can identify coinfections in a single assay [19, 44, 48, 51]. Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas12a-based diagnostic platforms combined with recombinase polymerase amplification (RPA) have been developed for rapid, point-of-care detection of A. platys DNA, with results available in under one hour. These methods are particularly valuable in resource-limited settings.

Serology

Serologic detection of antibodies against A. platys is complicated by cross-reactivity with other Anaplasma species and Ehrlichia canis [49, 71]. Commercial ELISA kits (here referred to generically) based on specific recombinant antigens, such as those identified by high-throughput peptide microarrays, are under development to improve serodiagnostic specificity [10]. Currently, serologic testing is most useful for epidemiologic surveys rather than for individual clinical diagnosis [17, 29, 39].

Hematologic and Biochemical Analysis

Automated hematology analyzers provide rapid platelet counts and flag abnormal distributions. Serial platelet monitoring is recommended to capture the cyclic nadir. Additionally, parameters such as mean platelet volume (MPV) may increase during recovery from thrombocytopenia. Serum biochemistry often reveals mild hypoalbuminemia or increased globulins, consistent with chronic inflammation [34, 52].

Diagnostic Algorithm

The following Mermaid diagram outlines a recommended diagnostic workflow for a dog suspected of thrombocytotropic anaplasmosis.

flowchart TD
 A[Dog with thrombocytopenia, fever, lethargy] --> B{Peripheral blood smear}
 B -->|Visible A. platys mortulae in platelets| C[Presumptive diagnosis]
 B -->|No visible mortulae| D[Serial smears or PCR]
 D --> E{Real-time PCR for A. platys}
 E -->|Positive| C
 E -->|Negative| F{Consider co-infections}
 F --> G["Multiplex PCR: E. canis, Babesia, Bartonella"]
 G --> H[Treat accordingly]
 C --> I[Confirm with PCR if needed]
 I --> J[Monitor platelet count every 2-3 days]
 J --> K[Response to doxycycline]

Treatment and Prognosis

Doxycycline is the first-line antibiotic for canine anaplasmosis [34, 52]. The recommended dose is 5 to 10 mg/kg orally every 12 hours for 14 to 28 days [34, 52]. In dogs with severe thrombocytopenia or bleeding tendencies, supportive care including platelet transfusions or fresh whole blood may be necessary [45, 58]. Clinical response is generally favorable, with platelet counts returning to normal within 5 to 14 days of initiating therapy [34, 52]. Persistent or recurrent infection may occur if treatment is inadequate or if reinfection occurs due to ongoing tick exposure. The prognosis for uncomplicated A. platys infection is excellent, whereas coinfected dogs may require longer or additional antimicrobial therapy [34, 52, 58].

Epidemiology and Risk Factors

Anaplasma platys has a worldwide distribution, with prevalence rates varying widely by geographic region, canine population, and diagnostic method used. Molecular surveys have reported infection rates from less than 1% to over 60% in endemic areas [2, 3, 4, 7, 9, 11, 12, 13, 14, 15, 17, 18, 19, 21, 22, 23, 24, 28, 29, 30, 31, 32, 33, 35, 36, 37, 38, 39, 40, 41, 42, 43, 45, 46, 47, 48, 49, 50, 52, 53, 54, 55, 56, 57, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73]. Significant risk factors for infection include living in warm, humid climates where R. sanguineus is abundant, being a stray or free-roaming dog, and lacking consistent ectoparasitic control [2, 5, 7, 13, 14, 17, 19, 21, 24, 33, 35, 38, 41, 45, 50, 56, 66, 67]. Male dogs and certain age groups may also be at increased risk [13, 38, 45]. Coinfections with E. canis and Babesia vogeli are particularly common in tropical regions [3, 4, 5, 11, 18, 21, 34, 61].

Notably, A. platys has been detected in a broad range of mammals beyond dogs, including cats, livestock (sheep, cattle), and wildlife such as coatis and opossums, suggesting a wide host range and potential for cross-species transmission [5, 6, 8, 54, 58, 59, 60, 63]. A systematic review of A. platys in Africa highlights knowledge gaps regarding its prevalence in wild and domestic animal reservoirs [8].

Prevention and Control

Prevention relies primarily on reducing exposure to ticks. Regular application of acaricides (topical spot-ons, collars, oral formulations) is effective against R. sanguineus [24, 41, 50]. Environmental management, including kennel hygiene and tick control in the dog's living area, is equally important. There is currently no commercially available vaccine for A. platys. Screening of blood donors using PCR is recommended to prevent transfusion transmission [12, 72].

Conclusion

Anaplasma platys is a significant cause of thrombocytopenia in dogs worldwide. Its diagnosis requires a high index of clinical suspicion and the strategic use of molecular assays to overcome the limitations of direct microscopy. The development of rapid, field-deployable molecular tests (e.g., CRISPR-Cas12a-RPA) offers promise for earlier and more sensitive detection, especially in endemic regions with limited laboratory infrastructure. Continued surveillance, coupled with comprehensive tick control programs, remains essential to mitigate the impact of this pathogen on canine health.

References

[1] Pati M, Patra RC, Dehuri M, et al. Development of hexaplex PCR assay for the detection and characterization common tick-borne pathogens in dogs, and analysis of risk factors. Vet Anim Sci. 2026.

[2] Pham BX, Phoosangwalthong P, Inkaew T, et al. The Comparative Study for Detection of Canine Vector-Borne Pathogens Between Companion and Stray Dogs in Bangkok and Vicinities, Thailand. Pathogens. 2026.

[3] García Ríos IJM, Sebastian PS, Vaschalde PJ, et al. Circulation of Anaplasma platys, Babesia vogeli and Ehrlichia canis in dogs from eastern Salta Province, Argentina. Vet Parasitol Reg Stud Reports. 2026.

[4] Araújo BVS, Bezerra ILPD, Leite GL, et al. Epidemiological and clinicopathological factors associated with infection by multiple pathogens transmitted by Rhipicephalus sanguineus sensu lato in naturally infected dogs in the Semiarid area of Northeastern Brazil. Comp Immunol Microbiol Infect Dis. 2026.

[5] Cordeiro MD, Magalhães-Matos PC, Dias IDS, et al. High prevalence of a host-associated Anaplasma lineage in wild coatis (Nasua nasua) from the Brazilian Atlantic Forest. Med Vet Entomol. 2026.

[6] Dallmann PRJ, Lima DD, Silveira CX, et al. First report of multiple infection by Anaplasma platys, Bartonella henselae, and hemoplasmas in clinically healthy domestic cats from Southern Brazil. Vet Res Commun. 2026.

[7] Kongtawee R, Junsiri W, Narapakdeesakul D, et al. High burden and spatial clustering of canine hemoparasitic infections in southern Thailand: A molecular survey of free-roaming dogs. One Health. 2026.

[8] Mnisi ZTH, Makgabo SM, Byaruhanga C. Anaplasma platys beyond canines: a systematic review of host range, phylogenetic relatedness, and knowledge gaps in Africa. Parasit Vectors. 2026.

[9] Venugopal V, Deepa PM, Muhasin Asaf VN, et al. Molecular epidemiology and phylogenetics of canine haemoprotozoan and rickettsial infections in southern India. Vet Parasitol Reg Stud Reports. 2026.

[10] Llanes A, Madesh S, Brangulis K, et al. High-throughput identification of immunoreactive peptides and corresponding proteins from Anaplasma platys and Ehrlichia canis using peptide microarray chips. Front Cell Infect Microbiol. 2025.

[11] Araújo BVS, Bezerra ILPD, Leite GL, et al. Single and co-infections by Anaplasma platys, Babesia vogeli, Ehrlichia canis, and Hepatozoon canis in dogs from Rio Grande do Norte, Brazil: frequency and molecular characterization. Rev Bras Parasitol Vet. 2025.

[12] da Silva JVDSA, das Neves LF, Bolzan ME, et al. Molecular Survey of Hemopathogens in Dogs, Including Blood Donors, from Central-Western Brazil. Pathogens. 2025.

[13] Perera V, Eremeeva ME, Dangolla A, et al. Canine Anaplasmoses in south and Southeast Asia: A systematic review. Vet Parasitol Reg Stud Reports. 2025.

[14] Phommadeechack V, Sungvornyothin S, Pan-Ngum W, et al. Identification and pathogen screening of ectoparasites from companion animals in urban Vientiane, Lao PDR. PLoS Negl Trop Dis. 2025.

[15] Ullah S, Zhao J, Almutairi MM, et al. Toxicosis in human and domestic hosts caused by ixodid ticks detected with Anaplasma platys and Hepatozoon ayorgbor. Acta Trop. 2025.

[16] de Matos ER, Dos Santos PN, Zweygarth EP, et al. Isolation, Molecular Characterization and In Vitro Propagation of an Anaplasma platys-Like Bacterium in Tick Cells. Pathogens. 2025.

[17] Rivera Villar J, Aquino Escalante I, Chuchón Martínez S, et al. Seroprevalence and Risk Factor for Canine Tick-Borne Disease in Urban-Rural Area in Ayacucho, Peru. Trop Med Infect Dis. 2025.

[18] Rodrigues PHC, de Almeida Curi NH, Barbosa EP, et al. Rural dogs (Canis familiaris) as sentinels to ectoparasites and tick borne pathogens around six Atlantic Forest conservation units in Brazil. Vet Parasitol. 2025.

[19] Daniel IK, Hakimi H, Ramos RAN, et al. High prevalence of vector-borne protozoa and bacteria in dogs from Chad determined using a targeted next-generation sequencing approach. Sci Rep. 2025.

[20] Hosein A, Sant C, Pargass I, et al. A comparison of reverse line blot hybridization and IDEXX SNAP 4Dx test in detecting canine anaplasmosis/ehrlichiosis in Trinidad. Ticks Tick Borne Dis. 2025.

[21] Araújo BVS, Carmo LDAOD, Amora SSA, et al. Molecular survey of tick-borne pathogens in domestic dogs from a rural region within the buffer zone of a conservation unit in the Brazilian Caatinga biome. Rev Bras Parasitol Vet. 2025.

[22] Bhowmik P, Kumar M, Lalrinkima H, et al. First report on the molecular characterization and successful treatment of Anaplasma platys infection in a dog from Tripura, northeast India. Vet Ital. 2025.

[23] Alvi MA, Javaid T, Yameen AB, et al. Molecular detection and genetic diversity of Anaplasma and Ehrlichia species in livestock and dogs in Pakistan. Acta Trop. 2025.

[24] Aryal S, Bhattarai RK, Thapa K. Comprehensive study of ticks and tick-borne diseases in dogs in Nepal: molecular identification, risk analysis and hematological alterations. BMC Vet Res. 2025.

[25] Nkosi NF, Byaruhanga C, Arega SM, et al. Development and validation of a real-time PCR assay, and phylogenetic analysis of Anaplasma platys. Vet Parasitol. 2025.

[26] Huang XB, Tang T, Chen JJ, et al. The global distribution and risk prediction of Anaplasmataceae species: a systematic review and geospatial modelling analysis. EBioMedicine. 2025.

[27] Chisu V, Zobba R, Masala G, et al. Emergence of Novel Anaplasma Species in the Mediterranean Area. Animals (Basel). 2025.

[28] Badillo-Viloria M, Mattar S, Remesar S, et al. Rickettsia spp. and Anaplasmataceae in Ticks From Domestic Animals in Northern Colombia. Zoonoses Public Health. 2025.

[29] Khalifa MM, Salem MA, Fouad EA, et al. Vector-borne pathogens in dogs in Egypt: Molecular and immunological insights. Res Vet Sci. 2025.

[30] Gospodinova K, Petrov V, Stanilov I, et al. First molecular evidence of Anaplasma platys infection in a dog (Labrador retriever) from Bulgaria. Open Vet J. 2024.

[31] Zahri A, Jimale KA, Bezerra-Santos MA, et al. Vector-borne pathogens in dogs and in Rhipicephalus sanguineus sensu stricto ticks in Morocco. Acta Trop. 2025.

[32] Arif ED, Khan KMH, Al-Sada IHA, et al. Molecular detection of Anaplasma platys in Pshdar Kurdish shepherd dogs of Sulaymaniyah Province, Iraq. Vet World. 2024.

[33] Jeréz-Sulvarán IA, Martínez-Herrera DI, Vivanco-Cid H, et al. Frequency of Anaplasma platys in dogs from the municipality of Veracruz, Mexico. Vet Res Forum. 2024.

[34] Wongtawan T, Sontigun N, Boonchuay K, et al. Improvements in Blood Profiles of Canines Naturally Infected with Triple Blood Pathogens (Babesia vogeli, Ehrlichia canis, and Anaplasma platys) Subsequent to Doxycycline Monotherapy. Animals (Basel). 2024.

[35] Pandey GS, Pathak CR, Thapa S, et al. Exploring tick-borne pathogens in community dogs in Nepal. Parasitol Int. 2025.

[36] Kumar GS, Varghese A, Bora CAF, et al. Haemoprotozoan and haemorickettsial carrier status in pet and community owned dogs of south India. Vet Parasitol Reg Stud Reports. 2024.

[37] Maas LMI, Winter M, Herrmann V, et al. Anaplasma platys and Rickettsia massiliae in Rhipicephalus sanguineus sensu stricto ticks collected on dogs in the Patagonian region of Argentina. Parasitology. 2024.

[38] Jayatilaka PS, Ranatunga RAS, Wijerathna HSU, et al. Canine vector-borne infections of working dogs of the Sri Lanka Air Force, and free roaming, and privately owned dogs. Sci Rep. 2024.

[39] Cornejo A, Davila R, Gomez-Puerta LA. Molecular detection of Ehrlichia spp., Anaplasma spp., and Bartonella spp. in dogs treated at a veterinary teaching clinic in Peru. Comp Immunol Microbiol Infect Dis. 2024.

[40] Salvioni Recalde OD, Rolón MS, Velázquez MC, et al. Diversity of Anaplasmataceae Transmitted by Ticks (Ixodidae) and the First Molecular Evidence of [Anaplasma phagocytophilum](/knowledge/bacteria/Equine Granulocytic Anaplasmosis/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick) and Candidatus Anaplasma boleense in Paraguay. Microorganisms. 2024.

[41] Chao LL, Ko PY, Shih CM. Molecular Screening and Genetic Identification of Anaplasma platys in Brown Dog Tick (Rhipicephalus sanguineus s. l.) Infested on Stray Dogs in Taiwan. Microorganisms. 2024.

[42] Haynes E, Garrett KB, Grunert RKA, et al. Surveillance of tick-borne pathogens in domestic dogs from Chad, Africa. BMC Vet Res. 2024.

[43] Checa R, Peteiro L, Pérez-Hernando B, et al. High serological and molecular prevalence of Ehrlichia canis and other vector-borne pathogens in dogs from Boa Vista Island, Cape Verde. Parasit Vectors. 2024.

[44] Huggins LG, Namgyel U, Wangchuk P, et al. Metabarcoding using nanopore sequencing enables identification of diverse and zoonotic vector-borne pathogens from neglected regions: A case study investigating dogs from Bhutan. One Health. 2024.

[45] Do T, Bui KL, Zafar I, et al. Molecular detection, risk factors, and phylogenetic analysis of tick-borne pathogens in dogs from northern Vietnam. Trop Biomed. 2024.

[46] Parodi P, Bazzano V, Armúa-Fernández MT, et al. Molecular survey of Piroplasmida, Hepatozoon spp. and Anaplasmataceae in anemic and thrombocytopenic dogs from Uruguay. Vet Parasitol Reg Stud Reports. 2024.

[47] Ghodrati S, Lesiczka PM, Zurek L, et al. Rhipicephalus sanguineus from Hungarian dogs: Tick identification and detection of tick-borne pathogens. Vet Parasitol Reg Stud Reports. 2024.

[48] Davitt C, Huggins LG, Pfeffer M, et al. Next-generation sequencing metabarcoding assays reveal diverse bacterial vector-borne pathogens of Mongolian dogs. Curr Res Parasitol Vector Borne Dis. 2024.

[49] Facile V, Sabetti MC, Balboni A, et al. Detection of Anaplasma spp. and Ehrlichia spp. in dogs from a veterinary teaching hospital in Italy: a retrospective study 2012-2020. Vet Res Commun. 2024.

[50] Mohanta UK, Marguerite MP, Ji S, et al. Molecular survey of canine tick-borne pathogens in ticks and stray dogs in Dhaka city, Bangladesh. Parasitol Int. 2024.

[51] Díaz-Corona C, Roblejo-Arias L, Piloto-Sardiñas E, et al. Microfluidic PCR and network analysis reveals complex tick-borne pathogen interactions in the tropics. Parasit Vectors. 2024.

[52] Chikufenji B, Chatanga E, Galon EM, et al. First report of dog ticks and tick-borne pathogens they are carrying in Malawi. J Vet Med Sci. 2024.

[53] Atapattu U, Colella V, Worsley A, et al. Prevalence, Distribution, and Factors Associated with Vector-Borne Pathogen Infections in Pet Dogs from Different Geoclimatic Zones in Sri Lanka. Transbound Emerg Dis. 2023.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.